RECRUITING

Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized clinical trial is to test the effect of patient education on extent of use of guideline directed medical treatment (GDMT) of heart failure with reduced ejection fraction. The main question that our study aims to answer is if patient education can improve the adherence to GDMT in heart failure with reduced ejection fraction. Participants will receive educations about GDMT benefits in 1,3 and 5 months after discharge from hospital.

Official Title

Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction- A Randomized Controlled Trial

Quick Facts

Study Start:2024-02-01
Study Completion:2025-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06273085

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients diagnosed with Heart Failure reduced Ejection Fraction (EF≤40%)
  2. * Age \>18 years
  3. * Able to consent for enrollment.
  4. * Hospitalized at one of the Medstar facilities (Inpatient)
  1. * Pregnancy
  2. * Patient with stage D heart failure candidates for advanced therapies or on home inotropes or receiving hospice service
  3. * Patients with advanced organ failure (End stage cancer, Advanced dementia, MELD (Model for End-Stage Liver Disease) score \> 30, GFR (Glomerular filtration rate) \<25) in whom GDMT is Futile
  4. * Patients with Heart failure Collaboratory Score (HFCS) of 9

Contacts and Locations

Study Contact

Anup Agarwal, MD
CONTACT
5066207815
anup.agarwal@medstar.net
Sumanth Bandaru, MBBS
CONTACT
6462405289
sumanthkumar.bandaru@medstar.net

Principal Investigator

Anup Agarwal, MD
PRINCIPAL_INVESTIGATOR
MedStar Health

Study Locations (Sites)

Medstar Union Memorial Hospital
Baltimore, Maryland, 21218
United States
Medstar Harbor Hospital
Baltimore, Maryland, 21225
United States
Medstar Franklin Medical Center
Baltimore, Maryland, 21237
United States
Medstar Good Samaritan Hospital
Baltimore, Maryland, 21239
United States

Collaborators and Investigators

Sponsor: Medstar Health Baltimore

  • Anup Agarwal, MD, PRINCIPAL_INVESTIGATOR, MedStar Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-01
Study Completion Date2025-02

Study Record Updates

Study Start Date2024-02-01
Study Completion Date2025-02

Terms related to this study

Keywords Provided by Researchers

  • heart failure with reduced ejection fraction
  • patient education

Additional Relevant MeSH Terms

  • Heart Failure
  • Patient Acceptance of Health Care